Portola Pharmaceuticals Names Scott Garland President and Chief Executive Officer

– Relypsa president and former Exelixis chief commercial officer brings significant commercial and operational expertise – ...

OncoMed Provides Update on Navicixizumab Partnership

REDWOOD CITY, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ: OMED), ...

TESARO Announces Participation at Two Investor Conferences

WALTHAM, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused ...